<DOC>
	<DOCNO>NCT01391468</DOCNO>
	<brief_summary>This randomize double blind placebo control study perform Chronic Kidney Disease ( CKD ) patient . After informed consent , intervention group receive probiotic contain 109 CFU B. bifidum , B.catenulatum , B. longum , L.plantarm ) , placebo group receive corn starch . In first year investigator examine 60 peritoneal dialysis ( PD ) patient , second year investigator 60 hemodialysis ( HD ) patient , third year investigator 60 stage 3 4 CKD patient . Primary endpoint cardiovascular event , gastrointestinal symptom , peritonitis PD patient , progression stage 3 4 CKD . Values compare group unpaired test . X2 testis use compare proportion group . Relative risk number need treat , 95 % CI , use describe treatment effect probiotic . A p value le 0•05 regard statistically significant .</brief_summary>
	<brief_title>Beneficial Effect Probiotics Chronic Kidney Disease</brief_title>
	<detailed_description>Chronic kidney disease ( CKD ) global health issue substantial impact affected individual . The prognosis dialysis patient poor 30 50 percent 5 year survival nondiabetic patient 25 percent diabetic . Cardiovascular disease account approximately half death dialysis patient Chronic inflammation , widely see long-term dialysis patient , associate malnutrition , atherosclerosis increase mortality risk . Inflammatory marker C-reactive protein ( CRP ) , IL-6 , Il-18 TNF-α , elevate dialysis predict cardiovascular event all-cause mortality . Probiotics microorganisms beneficial property host . Three describe benefit include suppression growth epithelial binding/invasion pathogenic bacteria , improvement intestinal barrier function modulation immune system . Several probiotic preparation induce protective cytokine , include IL-10 , suppress proinflammatory cytokine , TNF-α IL-6 . Intestinal microflora derange hemodialysis ( HD ) patient increase aerobic bacteria E. coli decrease anaerobic bacteria Bifidobacterium . One study report oral administration ifidobacterium longum gastroresistant seamless capsule decrease pre-HD serum level homocysteine indoxyl sulfate . Another small-scale study Japan show synbiotics contain lactobacillus reduce serum level p-Cresol HD patient . High-serum p-cresyl sulfate indoxyl sulfate level associate renal progression . Serum concentration p-cresol independently associate overall mortality cardiovascular disease HD patient . The aim study 1. evaluate difference intestinal microflora CKD patient healthy control ; 2. evaluate whether investigator reduce cardiovascular event CKD patient , peritonitis peritoneal dialysis ( PD ) patient , retard progression stage 3 4 CKD patient , decrease circulate inflammatory marker ( CRP , IL-6 , IL-18 , TNF-α ) , indoxyl sulfate , p-cresol homocysteine probiotic treatment . Randomized double blinded placebo control study perform CKD patient . After informed consent , intervention group receive probiotic contain 109 CFU B. bifidum , B.catenulatum , B. longum , L.plantarm ) , placebo group receive corn starch . In first year investigator examine 60 PD patient , second year investigator 60 HD patient , third year investigator 60 stage 3 4 CKD patient . Primary endpoint cardiovascular event , gastrointestinal symptom , peritonitis PD patient , progression stage 3 4 CKD . Values compare group unpaired test . X2 testis use compare proportion group . Relative risk number need treat , 95 % CI , use describe treatment effect probiotic . A p value le 0·05 regard statistically significant .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>1. receive peritoneal dialysis 3 month , least 18 year age , GFR &lt; 15 ml/min . 2. receive hemodialysis dialysis 3 month , least 18 year age , GFR &lt; 15 ml/min . 3 . Stage 3 4 CKD patient active infectious condition within last 30 day , pregnancy female , autoimmune disease e.g . SLE. , cardiovascular event .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>